ISLE
Income statement / Annual
Last year (2021), Isleworth Healthcare Acquisition Corp.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2021, Isleworth Healthcare Acquisition Corp.'s net income was $10.58 M.
See Isleworth Healthcare Acquisition Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2021
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
FY-2011
|
FY-2010
|
FY-2009
|
FY-2008
|
FY-2007
|
| Period Ended |
12/31/2021 |
04/24/2016 |
04/26/2015 |
04/27/2014 |
04/28/2013 |
04/29/2012 |
04/24/2011 |
04/25/2010 |
04/26/2009 |
04/27/2008 |
| Operating Revenue |
$0.00 |
$978.59 M |
$996.28 M |
$954.60 M |
$965.20 M |
$977.37 M |
$1.01 M |
$999,000.00 |
$1.12 M |
$1.13 B |
| Cost of Revenue |
$0.00
|
$180,000.00
|
$188,000.00
|
$179.42 M
|
$175,000.00
|
$169,000.00
|
$179,000.00
|
$179,000.00
|
$193,000.00
|
$182.02 M
|
| Gross Profit |
$0.00
|
$978.41 M
|
$996.09 M
|
$775.18 M
|
$965.02 M
|
$977.20 M
|
$826,000.00
|
$820,000.00
|
$925,000.00
|
$943.33 M
|
| Gross Profit Ratio |
0
|
1
|
1
|
0.81
|
1
|
1
|
0.82
|
0.82
|
0.83
|
0.84
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$836,518.00
|
$219.86 M
|
$234.24 M
|
$0.00
|
$235.91 M
|
$234.24 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$220,000.00
|
$234,000.00
|
$234.69 M
|
$236,000.00
|
$234,000.00
|
$253,000.00
|
$253,000.00
|
$263,000.00
|
$290.59 M
|
| Selling, General & Administrative Expenses |
$836,518.00
|
$220.08 M
|
$234.47 M
|
$234.69 M
|
$236.15 M
|
$234.47 M
|
$253,000.00
|
$253,000.00
|
$263,000.00
|
$290.59 M
|
| Other Expenses |
$0.00
|
$635.37 M
|
$658.00 M
|
$787.48 M
|
$680.10 M
|
$658.52 M
|
$656,000.00
|
$682,000.00
|
$724,000.00
|
$870.84 M
|
| Operating Expenses |
$836,518.00
|
$855.45 M
|
$892.47 M
|
$1.02 B
|
$916.25 M
|
$892.99 M
|
$909,000.00
|
$935,000.00
|
$987,000.00
|
$1.16 B
|
| Cost And Expenses |
$836,518.00
|
$855.63 M
|
$892.66 M
|
$1.20 B
|
$916.42 M
|
$893.16 M
|
$1.09 M
|
$1.11 M
|
$1.18 M
|
$1.34 B
|
| Interest Income |
$60,533.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$60,533.00
|
$68.03 M
|
$84.13 M
|
$81.34 M
|
$89.46 M
|
$87.91 M
|
$91,000.00
|
$75,000.00
|
$92,000.00
|
$109.29 M
|
| Depreciation & Amortization |
$5.74 M
|
$86.24 M
|
$83.92 M
|
$86.95 M
|
$81.10 M
|
$89.81 M
|
$89.04 M
|
$109.50 M
|
$127.22 M
|
$136.13 M
|
| EBITDA |
$4.90 M |
$204.65 M |
$174.34 M |
$22.11 M |
$129.72 M |
$63.08 M |
$89.14 M |
$109.57 M |
$127.32 M |
$213.36 M |
| EBITDA Ratio |
0
|
0.21
|
0.17
|
0.02
|
0.13
|
0.06
|
88.69
|
109.68
|
113.88
|
0.19
|
| Operating Income Ratio |
0
|
0.12
|
0.09
|
-0.07
|
0.05
|
-0.03
|
0.09
|
0.07
|
0.09
|
0.07
|
| Total Other Income/Expenses Net |
$5.68 M
|
-$65.94 M
|
-$84.13 M
|
-$83.32 M
|
-$87.88 M
|
$24.47 M
|
-$91,000.00
|
-$75,000.00
|
$3,000.00
|
-$234.06 M
|
| Income Before Tax |
$4.84 M
|
$52.47 M
|
$6.29 M
|
-$148.16 M
|
-$39.26 M
|
-$2.26 M
|
$4,000.00
|
-$9,000.00
|
$99,000.00
|
-$156.83 M
|
| Income Before Tax Ratio |
0
|
0.05
|
0.01
|
-0.16
|
-0.04
|
-0
|
0
|
-0.01
|
0.09
|
-0.14
|
| Income Tax Expense |
-$5.74 M
|
$4.18 M
|
$1.11 M
|
-$18.49 M
|
$6.73 M
|
$15.12 M
|
-$3,000.00
|
$8,000.00
|
-$39,000.00
|
$64.82 M
|
| Net Income |
$10.58 M
|
$48.29 M
|
$5.18 M
|
-$129.67 M
|
-$45.99 M
|
-$17.38 M
|
$7,000.00
|
-$17,000.00
|
$138,000.00
|
-$221.65 M
|
| Net Income Ratio |
0
|
0.05
|
0.01
|
-0.14
|
-0.05
|
-0.02
|
0.01
|
-0.02
|
0.12
|
-0.2
|
| EPS |
0.47 |
1.19 |
0.13 |
-3.26 |
-1.17 |
-0.45 |
0.0002 |
-0.0005 |
0.0043 |
-7.22 |
| EPS Diluted |
0.47 |
1.17 |
0.13 |
-3.26 |
-1.17 |
-0.45 |
0.0002 |
-0.0005 |
0.0043 |
-7.22 |
| Weighted Average Shares Out |
$22.62 M
|
$40.69 M
|
$39.96 M
|
$39.73 M
|
$39.34 M
|
$38.75 M
|
$32.72 M
|
$32.18 M
|
$32.18 M
|
$30.70 M
|
| Weighted Average Shares Out Diluted |
$22.62 M
|
$41.32 M
|
$40.32 M
|
$39.73 M
|
$39.34 M
|
$38.75 M
|
$32.72 M
|
$32.18 M
|
$32.18 M
|
$30.70 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
